Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Sell
30
IMDX Quote, Financials, Valuation and Earnings
Last price:
$2.94
Seasonality move
:
-2.21%
Day range:
$2.68 - $2.88
52-week range:
$1.92 - $4.75
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
12.83x
P/B ratio:
7.92x
Volume:
20K
Avg. volume:
115.9K
1-year change:
-13.98%
Market cap:
$80.9M
Revenue:
$1.9M
EPS (TTM):
-$3.53
Earnings Data
Next earnings date for IMDX
Aug 08
2025
Most recent earnings per share
-$0.26
Missed by $0.01
(May 12/2025)
Consensus Estimate
-$0.25
(May 12/2025)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
IMDX Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 09/30/2025 | Q3 | $283.9K | -- | -- | -$0.25 | -- |
| 08/08/2025 | Q2 | $292K | -- | -- | -$0.24 | -- |
| 05/12/2025 | Q1 | $126.8K | $2.1M | -$0.26 | -$0.25 | -$0.01 |
| 12/31/2024 | Q4 | $101.7K | $1.5M | -$1.93 | -- | -- |
| 09/30/2024 | Q3 | $168.3K | $115K | -$0.98 | -- | -- |
| 06/30/2024 | Q2 | $312.4K | $104K | -$0.36 | -$0.37 | $0.01 |
| 03/31/2024 | Q1 | $350K | $176K | -$1.13 | -$0.57 | -$0.56 |
| 12/31/2023 | Q4 | $316.7K | $314K | -$2.07 | -- | -- |
| 09/30/2023 | Q3 | $312.5K | $429K | -$0.81 | -$0.78 | -$0.03 |
| 06/30/2023 | Q2 | $350K | $463K | -$1.07 | -$0.59 | -$0.48 |
| 03/31/2023 | Q1 | -- | $297K | $0.40 | -- | -- |
| 12/31/2022 | Q4 | -- | $274K | -$8.03 | -- | -- |
| 09/30/2022 | Q3 | -- | $67K | -$1.62 | -- | -- |
| 06/30/2022 | Q2 | -- | $237K | -$1.48 | -- | -- |
| 03/31/2022 | Q1 | -- | $380K | -$2.20 | -- | -- |
| 12/31/2021 | Q4 | -- | -$1.9M | -$7.80 | -- | -- |
| 09/30/2021 | Q3 | -- | $984K | -$3.00 | -- | -- |
| 06/30/2021 | Q2 | -- | $2M | -$2.40 | -- | -- |
| 03/31/2021 | Q1 | -- | $1.1M | -$1.00 | -- | -- |
| 12/31/2020 | Q4 | -- | $503K | -$1.80 | -- | -- |
| 09/30/2020 | Q3 | -- | $555K | -$2.00 | -- | -- |
| 06/30/2020 | Q2 | -- | $143K | -$2.80 | -- | -- |
| 03/31/2020 | Q1 | -- | $16K | -$2.60 | -- | -- |
| 12/31/2019 | Q4 | -- | -- | -$3.00 | -- | -- |
| 09/30/2019 | Q3 | -- | -- | -$2.00 | -- | -- |
| 06/30/2019 | Q2 | -- | -- | -$2.07 | -- | -- |
| 03/31/2019 | Q1 | -- | -- | -$1.60 | -- | -- |
| 12/31/2018 | Q4 | -- | -- | -$2.20 | -- | -- |
| 09/30/2018 | Q3 | -- | -- | -$1.40 | -- | -- |
| 06/30/2018 | Q2 | -- | -- | -$2.40 | -- | -- |
| 03/31/2018 | Q1 | -- | -- | -$2.40 | -- | -- |
| 12/31/2017 | Q4 | -- | -- | -$2.60 | -- | -- |
| 09/30/2017 | Q3 | -- | -- | -$4.40 | -- | -- |
| 06/30/2017 | Q2 | -- | -- | -$2.60 | -- | -- |
| 03/31/2017 | Q1 | -- | -- | -$3.20 | -- | -- |
| 12/31/2016 | Q4 | -- | -- | -$2.20 | -- | -- |
| 09/30/2016 | Q3 | -- | -- | -$2.00 | -- | -- |
| 06/30/2016 | Q2 | -- | -- | -$2.00 | -- | -- |
| 03/31/2016 | Q1 | -- | -- | -$2.40 | -- | -- |
| 12/31/2015 | Q4 | -- | -- | -$2.80 | -- | -- |
| 09/30/2015 | Q3 | -- | -- | -$1.90 | -- | -- |
Insight Molecular Diagnostics Earnings Questions
-
How Much did Insight Molecular Diagnostics Generate in Revenue Last Quarter?
Insight Molecular Diagnostics reported $2.1M worth of top line sales in its most recent quarter.
-
Did Insight Molecular Diagnostics Beat Earnings Last Quarter?
Insight Molecular Diagnostics announced earnings per share of -$0.26 which represents a miss of analyst forecast a -$0.25 per share.
-
Is Insight Molecular Diagnostics Profitable?
Insight Molecular Diagnostics reported $1.3M that represents $0.05 per share over the last quarter.
-
What is the Analyst Consensus for Insight Molecular Diagnostics EPS Next Year?
Insight Molecular Diagnostics's earnings are forecast to decrease from -$4.66 per share to -$0.99 per share next year representing a decrease of -78.76%.
-
When is Insight Molecular Diagnostics's Earnings Date?
Insight Molecular Diagnostics's next earnings date is August 8, 2025.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will FCX Benefit From Tariffs?
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Can Levi Stock Double?
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Stock Ideas
Buy
70
Is NVDA Stock a Buy?
Market Cap: $4.2T
P/E Ratio: 58x
Buy
62
Is MSFT Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 43x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 35x
Alerts
Buy
82
SBET alert for Jul 17
SharpLink Gaming [SBET] is down 2.6% over the past day.
Buy
89
EXOD alert for Jul 17
Exodus Movement [EXOD] is down 4.14% over the past day.
Buy
60
U alert for Jul 17
Unity Software [U] is up 7.51% over the past day.
